Oxygen uptake efficiency slope correlates with brain natriuretic peptide in patients with heart failure

Cardiopulmonary exercise testing is a well-established tool for clinical and prognostic assessment of patients with chronic heart failure (CHF). Recently, a new parameter of this examination--oxygen uptake efficiency slope (OUES)--has been described and proposed as a new prognostic factor in patient...

Full description

Saved in:
Bibliographic Details
Published in:Cardiology journal 2010, Vol.17 (4), p.362-366
Main Authors: Straburzyńska-Migaj, Ewa, Gwizdała, Adrian, Siniawski, Andrzej, Ochotny, Romuald, Grajek, Stefan
Format: Article
Language:English
Subjects:
Adult
Biomarkers - blood
Cardiovascular disease
Case-Control Studies
Chi-Square Distribution
Chronic Disease
Efficiency
Ejection fraction
Exercise Test
Exercise Tolerance
Female
Fitness equipment
Heart failure
Heart Failure - blood
Heart Failure - diagnosis
Heart Failure - physiopathology
Humans
Male
Middle Aged
Multivariate Analysis
Natriuretic Peptide, Brain - blood
Oxygen - metabolism
Oxygen Consumption
Peptides
Poland
Predictive Value of Tests
Prognosis
Pulmonary Ventilation
Regression Analysis
Stroke Volume
Ventricular Function, Left
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiopulmonary exercise testing is a well-established tool for clinical and prognostic assessment of patients with chronic heart failure (CHF). Recently, a new parameter of this examination--oxygen uptake efficiency slope (OUES)--has been described and proposed as a new prognostic factor in patients with CHF. Brain natriuretic peptide (BNP) is an established prognostic factor in CHF. The purpose of the study was to assess OUES in patients with CHF in relation to other cardiopulmonary parameters and BNP levels. The study group consisted of 42 patients with CHF and left ventricular ejection fraction (LVEF) < 45% (mean age 50.2 +/- 9.3 years, mean ejection fraction 26.1 +/- 8.1% and NYHA functional class - 2.5 +/- 0.8) and eight healthy controls (age 43.6 +/- 14.7 years). Coronary artery disease was diagnosed in 16 patients (38%). All underwent maximal cardiopulmonary exercise treadmill test. BNP level was measured using Abbott AxSYM Immunoassay system. There were significant (p < 0.001) differences between the patients and controls in BNP levels (350 +/- 520 vs 14 +/- 19 pg/mL), OUES (1.7 +/- 0.4 vs 2.7 +/- 0.5), peak VO(2) (17.1 +/- +/- 5.1 vs 36.9 +/- 4.9 mL/kg/min), O(2) pulse (10.9 +/- 3.3 vs 15.9 +/- 2.7) and VE/VCO(2) slope (35.7 +/- 7.8 vs 25.7 +/- 2.7). In patients, OUES was significantly (p < 0.001) correlated with LVEF (r = 0.54), BNP levels (r = -0.49), peak VO(2) (r = 0.80), VO(2) AT (r = 0.65) and VE/VCO(2) slope (r = -0.59). BNP was independently related to OUES in multivariate regression analysis. Oxygen uptake efficiency slope is significantly reduced in patients with CHF and correlates with peak VO(2) and other parameters of cardiopulmonary exercise treadmill test. It is not related to age. BNP is an independent marker of OUES in patients with CHF.
ISSN:1897-5593
1898-018X